Author

admin

Browsing

Robinhood Markets, Inc. (HOOD) is back in the spotlight, wrestling with its four-year highs and turning heads on Wall Street. It debuted in 2021 as an IPO darling, capturing the imagination of young Gen Z traders before its dramatic fall as a meme stock fueled by crypto and an unhealthy dose of FOMO.

Now, with year-to-date gains outpacing the S&P 500 ($SPX), the former disruptor is looking to claim its space as a serious contender rather than a speculative fad.

Robinhood Stock’s Price Action: Breaking Out or Topping Out?

If you’ve been checking the StockCharts Technical Rank (SCTR) Reports, you’ve probably noticed the stock popping up on the Large Cap Top 10 list.

FIGURE 1. SCTR REPORT LARGE CAP TOP 10. Robinhood is second from the top.

If you’re eyeing HOOD, you’re likely asking two key questions: How is it performing relative to its Financials sector peers, and how strong is the sector itself in terms of market breadth? Just as important, you’ll want a longer-term view: How has the stock held up over time, both on its own and compared to the broader S&P 500?

Let’s tackle all those questions in one shot.

Financial Sector Breadth Shows Bullish Tailwinds for HOOD

The chart below, which tracks the Financial Sector Bullish Percent Index, offers a quick read on sector strength and market positioning.

NOTE: The BPI spans three years.

FIGURE 2. FINANCIAL SECTOR BPI. Market breadth and comparative price performance look exceedingly bullish.

From a breadth perspective, the Financial sector looks bullish, bordering on overbought, with over 82% of the stocks within the sector triggering Point & Figure Buy Signals, according to its Bullish Percent Index (BPI) reading. Meanwhile, HOOD is crushing it on a 3-year relative basis—outperforming its sector by 250% and the S&P 500 by nearly 300%.

This paints a bullish picture. But before jumping to conclusions, let’s take a step back and look at HOOD’s price history, going back to when it IPO’d in 2021.

From Meme Craze to Measured Recovery

Check out the weekly chart below.

FIGURE 3. WEEKLY CHART OF HOOD. It’s above the 10-week and 40-week SMAs, but it has quite a distance to go before testing its yearly high.

You don’t need annotations to spot where HOOD’s meme-stock frenzy peaked and where the crash began, fueled by a sharp drop in retail trading activity, crypto market volatility, and intensifying regulatory pressure.

After basing for two years, HOOD began picking up steam in 2024. Its improving technical strength is reflected in the sharp spike of its SCTR, breaking above the 90 line. Fundamentally, HOOD began to recover as it started raking in profits, expanding its product lineup, and reigniting its user growth.

It’s trading above its 10-week and 40-week simple moving average (SMA), which is equivalent to a 50-day and 200-day SMA, respectively. Still, it has quite a way to go before testing its high of $66.90.

Short-Term Trading Setup

If you’re looking to buy HOOD, you’ll need to zoom in to find favorable entry points. Let’s switch over to a daily chart.

FIGURE 4. DAILY CHART OF HOOD. Support levels are clear and accumulation looks promising.

HOOD was in an intermediate-term downtrend starting in early February, where it peaked at $66.90, all the way down to the early part of April, where it bottomed sharply at around $29. HOOD quickly recovered, breaking above $50 (a local swing high) to $54, where it is now (at the time of writing).

Can HOOD Hold Its Gains or Is Consolidation Coming?

The Stochastic Oscillator warns that HOOD may be overbought and due for a pullback. Here are a couple of scenarios to consider, and note that the Ichimoku Cloud visually provides a wider range of potential support:

  • Watch for support at $46 or $39, both recent swing lows.
  • If it stalls between those levels, it could signal a failed breakout and continued consolidation until a new catalyst emerges.
  • If it drops below $39, the next key level is at $29, but be a little cautious at that point, as such a deep retracement may indicate weakening momentum, sentiment, and fundamental weakness.

On the bullish side of things, the Accumulation/Distribution Line (ADL), currently well above the price, is indicating strong accumulation, suggesting that demand is outpacing supply—which, if it continues, can drive prices higher.

At the Close

Robinhood’s stock price is showing real signs of strength, not just on a chart, but in its fundamentals. With relative performance beating its sector and the S&P 500, and strong accumulation under the surface, HOOD’s comeback narrative is gaining technical validation. But with overbought signals flashing and key support levels in play, the next move may depend on whether bulls defend the breakout, or if the stock consolidates further while waiting for its next catalyst.

In either case, keep a close eye on volume, momentum shifts, and those support zones. HOOD may still have more room to run, but timing your entry could make all the difference.



Disclaimer: This blog is for educational purposes only and should not be construed as financial advice. The ideas and strategies should never be used without first assessing your personal and financial situation, or without consulting a financial professional.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES
  OR FOR DISSEMINATION IN THE UNITED STATES

Brunswick Exploration Inc. (‘ Brunswick ‘ or the ‘ Corporation ‘) (TSX-V: BRW, OTCQB: BRWXF) is pleased to announce that it has entered into an agreement with Red Cloud Securities Inc., to act as co-lead agent and sole bookrunner along with Canaccord Genuity Corp. as co-lead agent (collectively, the ‘ Agents ‘), in connection with a ‘best efforts’ private placement (the ‘ Marketed Offering ‘) for aggregate gross proceeds of up to C$2,500,000 from the sale of (i) units of the Corporation (the ‘ LIFE Units ‘) at a price of C$0.13 per LIFE Unit (the ‘ Offering Price ‘) and (ii) units of the Corporation (the ‘ Non-LIFE Units ‘, and collectively with the LIFE Units, the ‘ Offered Securities ‘) at a price of C$0.15 per Non-LIFE Unit. A strategic investor has made a lead order to subscribe for Non-LIFE Units under the Offering.

Each LIFE Unit will consist of one common share of the Corporation (each, a ‘ Unit Share ‘) and one half of one common share purchase warrant (each whole warrant, a ‘ LIFE Warrant ‘). Each whole LIFE Warrant will entitle the holder thereof to purchase one common share of the Corporation (each, a ‘ Warrant Share ‘) at a price of C$0.20 at any time for a period of 36 months following the Closing Date (as defined herein).

Each Non-LIFE Unit will consist of one Unit Share and one common share purchase warrant (each, a ‘ Non-LIFE Warrant ‘). Each Non-LIFE Warrant will entitle the holder thereof to purchase one Warrant Share at a price of C$0.25 at any time for a period of 36 months following the Closing Date.

The Agents will have an option, exercisable in full or in part, up to 48 hours prior to the Closing Date, to raise up to C$1,000,000 in additional gross proceeds from the sale of LIFE Units at the Offering Price (the ‘ Agents’ Option ‘, and together with the Marketed Offering, the ‘ Offering ‘).

Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 – Prospectus Exemptions (‘ NI 45-106 ‘), the LIFE Units will be offered for sale to purchasers in all the provinces of Canada (the ‘ Canadian Selling Jurisdictions ‘) pursuant to the listed issuer financing exemption under Part 5A of NI 45-106. The securities to be issued pursuant to the sale of LIFE Units are expected to be immediately freely tradeable under applicable Canadian securities legislation if sold to purchasers resident in Canada.

The Non-LIFE Units will be offered by way of the ‘accredited investor’ and ‘minimum amount investment’ exemptions under NI 45-106 in the Canadian Selling Jurisdictions. The securities to be issued pursuant to the sale of Non-LIFE Units will be subject to a four-month hold period in Canada pursuant to applicable Canadian securities laws.

The Offered Securities may also be issued to purchasers outside of Canada, including to purchasers resident in the United States pursuant to one or more exemptions from the registration requirements of the United States Securities Act of 1933 (the ‘ U.S. Securities Act ‘), as amended.

The Corporation intends to use the net proceeds of the Offering for exploration activities at the Company’s Québec and Greenland projects, as well as for general corporate purposes and working capital.

The Offering is scheduled to close on May 28, 2025 (the ‘ Closing Date ‘), or such other date as the Corporation and the Agents may agree. Completion of the Offering is subject to certain conditions including, but not limited to the receipt of all necessary approvals, including the approval of the TSX Venture Exchange.

There is an offering document related to the Offering that can be accessed under the Corporation’s profile at www.sedarplus.ca and on the Corporation’s website at www.brwexplo.ca. Prospective investors should read this offering document before making an investment decision.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the U.S. Securities Act, as amended or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

About Brunswick Exploration

Brunswick Exploration is a Montreal-based mineral exploration company listed on the TSX-V under symbol BRW. The Corporation is focused on grassroots exploration for lithium in Canada, a critical metal necessary to global decarbonization and energy transition. The Corporation is rapidly advancing the most extensive grassroots lithium property portfolio in Canada and Greenland.

Investor Relations/information

Mr. Killian Charles, President and CEO (info@brwexplo.ca)

Cautionary Statement on Forward-Looking Information

This news release contains ‘forward-looking information’ within the meaning of applicable Canadian securities legislation based on expectations, estimates and projections as at the date of this news release. Such forward-looking information includes, but is not limited to, statements concerning the Corporation’s expectations with respect to the use of proceeds and the use of the available funds following completion of the Offering; the completion of the Offering and the date of such completion, approval of the TSX Venture Exchange and the filing of the offering document. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, delays in obtaining or failures to obtain required governmental, environmental or other project approvals; uncertainties relating to the availability and costs of financing needed in the future; changes in equity markets; inflation; fluctuations in commodity prices; delays in the development of projects; the other risks involved in the mineral exploration and development industry; and those risks set out in the Corporation’s public documents filed on SEDAR+ at www.sedarplus.ca. Although the Corporation believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Corporation disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Neither the TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this news release.

News Provided by GlobeNewswire via QuoteMedia

This post appeared first on investingnews.com

Errawarra Resources Ltd (ASX: ERW) is pleased to advise that it has awarded its inaugural drilling contract at the high-grade Elizabeth Hill Project, located in the Pilbara region of Western Australia.

HIGHLIGHTS:

  • Inaugural Drilling Contract awarded for Elizabeth Hill.
  • West Core Drilling has been awarded the diamond drilling contract under a partial drill for equity arrangement. Drilling is anticipated to commence imminently post EGM.
  • Drill targeting currently being finalised following site visit by Errawarra’s Management to ground truth targets.
  • Regional Soils program targeting regional structures with associated historical silver in soil anomalism is almost completed with 1,766 soils samples and 89 rock chip samples having been collected.
  • Rock chip sampling is aided using pXRF technology to qualitatively assess with the samples in the field.
  • Laboratory results are expected in 6-8 weeks.

Following a competitive tender process, the Company has awarded the diamond drilling contract to West Core Drilling. The upcoming drill program will be completed under a partial drill-for-equity arrangement and will focus on high-priority mine and near-mine targets. These include:

  • Near-surface mineralisation,
  • Down-plunge extensions, and
  • Strategic drill holes to enhance the geological understanding and structural orientation of the mineralised system.

Drilling is anticipated to commence in the week following the Company’s upcoming General Meeting (GM) planned for 19 May 2025.

Executive Director Bruce Garlick commented:

“We are delighted to partner with West Core as part of our inaugural drilling program. This contract award demonstrates our continued progression of the project, and we look forward to testing the asset with the drill bit in the coming weeks. It was also fantastic for the board to recently visit site and see all the readily available nearby infrastructure that could potentially feed into our development planning.”

Targeting for the drill program is currently being finalised, with active involvement from the Board of Errawarra and technical consultants ERM Consulting. A recent site visit completed by management has enabled ground-truthing of the high-priority targets.

As part of Errawarra’s ongoing project development and planning, management visited the Radio Hill processing plant, approximately 15 kilometres to the north which is owned by Artemis Resources (ASX: ARV) and currently in care and maintenance.

During the same site visit, the team also observed the almost completed regional soil sampling campaign which is targeting regional structures with associated historical silver in soil anomalism. A total 1,766 soil samples and 89 rock chips samples have been collected to date during this program which is anticipated to be completed in the coming week.

Click here for the full ASX Release

This post appeared first on investingnews.com

NorthStar Gaming Holdings Inc. (TSXV: BET) (OTCQB: NSBBF) (‘NorthStar’ or the ‘Company’) today announces that its principal regulator, the Ontario Securities Commission, has granted its request for a management cease trade order (‘MCTO’) effective May 8, 2025.

As previously announced on April 29, 2025, the Company applied for the MCTO due to a delay in filing its annual audited financial statements, management’s discussion and analysis and related certifications for the financial year ended December 31, 2024 (the ‘Annual Filings’) which were required to be filed by April 30, 2025.

The delay is primarily due to a restatement of certain amounts owed by the Company’s payment service providers as well as player loyalty bonuses for the prior fiscal years. During the year-end reconciliation process, the Company identified that its payment processor had deducted additional merchant fees from daily remittances, which had not been properly accounted for. Specifically, service provider fees (cost of revenue) were previously understated, while the amounts due from the payment processor and accounts receivable were overstated in the financial statements for the year ended December 31, 2023.

The Company is working diligently and expeditiously to complete the Annual Filings as soon as practicable, and currently anticipates it will be in a position to file the Annual Filings on or before May 15, 2025.

The MCTO restricts the Company’s Chief Executive Officer and the Chief Financial Officer from trading in the Company’s securities but does not affect the ability of other shareholders, including the public, to trade in securities of the Company.

About NorthStar

NorthStar proudly owns and operates NorthStar Bets, a Canadian-born casino and sportsbook platform that delivers a premium, distinctly local gaming experience. Designed with high-stakes players in mind, NorthStar Bets Casino offers a curated selection of the most popular games, ensuring an elevated user experience. Our sportsbook stands out with its exclusive Sports Insights feature, seamlessly integrating betting guidance, stats, and scores, all tailored to meet the expectations of a premium audience.

As a Canadian company, NorthStar is uniquely positioned to cater to customers who seek a high-quality product and an exceptional level of personalized service, setting a new standard in the industry. NorthStar is committed to operating at the highest level of responsible gaming standards.

NorthStar is listed in Canada on the TSX Venture Exchange (‘TSXV’) under the symbol ‘BET’ and in the United States on the OTCQB under the symbol ‘NSBBF’. For more information on the company, please visit: www.northstargaming.ca.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.

Cautionary Note Regarding Forward-Looking Information and Statements

This communication contains ‘forward-looking information’ within the meaning of applicable securities laws in Canada (‘forward-looking statements’), including without limitation, statements with respect to the following: expected performance of the Company’s business, and the timing of the release of the Company’s financial results. The foregoing is provided for the purpose of presenting information about management’s current expectations and plans relating to the future and allowing investors and others to get a better understanding of the Company’s anticipated financial position, results of operations, and operating environment. Often, but not always, forward-looking statements can be identified by the use of words such as ‘plans’, ‘expects’, ‘is expected’, ‘budget’, ‘scheduled’, ‘estimates’, ‘continues’, ‘forecasts’, ‘projects’, ‘predicts’, ‘intends’, ‘anticipates’ or ‘believes’, or variations of, or the negatives of, such words and phrases, or state that certain actions, events or results ‘may’, ‘could’, ‘would’, ‘should’, ‘might’ or ‘will’ be taken, occur or be achieved. This information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. This forward-looking information is based on management’s opinions, estimates and assumptions that, while considered by NorthStar to be appropriate and reasonable as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by such forward- looking information. Such factors include, among others, the following: risks related to the Company’s business and financial position; risks associated with general economic conditions; adverse industry risks; future legislative and regulatory developments; the ability of the Company to implement its business strategies; and those factors discussed in greater detail under the ‘Risk Factors’ section of the Company’s most recent annual information form, which is available under NorthStar’s profile on SEDAR+ at www.sedarplus.ca. Many of these risks are beyond the Company’s control.

If any of these risks or uncertainties materialize, or if the opinions, estimates or assumptions underlying the forward-looking information prove incorrect, actual results or future events might vary materially from those anticipated in the forward-looking statements. Although the Company has attempted to identify important risk factors that could cause actual results to differ materially from those contained in the forward-looking statements, there may be other risk factors not presently known to the Company or that the Company presently believes are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking statements. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. No forward-looking statement is a guarantee of future results. Accordingly, you should not place undue reliance on forward-looking information, which speaks only as of the date made. The forward-looking information contained in this press release represents NorthStar’s expectations as of the date specified herein, and are subject to change after such date. However, the Company disclaims any intention or obligation or undertaking to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable securities laws.

All of the forward-looking information contained in this press release is expressly qualified by the foregoing cautionary statements.

For further information:

Company Contact:
Corey Goodman
Chief Development Officer 647-530-2387
investorrelations@northstargaming.ca

Investor Relations:
RB Milestone Group LLC (RBMG)
Northstar@rbmilestone.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/251431

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the initial disappointment cast a shadow over the psychedelics industry.

However, the sector is seeing a resurgence of optimism in 2025 on the back of various US developments.

“The psychedelic industry in 2025 will likely see significant advancements in clinical applications, particularly in treating PTSD, depression, and addiction, as research continues to validate their therapeutic potential,” Dr. Markus Ploesser, chief innovation officer at Open Mind Health, told Microdose in January.

This sentiment is underscored by a variety of recent positive developments, including the FDA’s approval of Johnson & Johnson’s (NYSE:JNJ) ketamine-derived nasal spray to combat treatment-resistant depression, and an initiative to study MDMA-assisted therapy efficacy for post-traumatic stress disorder (PTSD) and alcohol use disorder in veterans.

In addition, alternative medicine advocate Robert F. Kennedy Jr.’s appointment as head of the US Department of Health and Human Services has created potential for further policy shifts related to mental health and psychedelics research.

Combined, these factors could make 2025 a pivotal year for the industry.

Legal state psychedelics markets take shape

Psychedelic compounds remain federally illegal in the US, but some states have pursued legalization and decriminalization. In November 2020, Oregon became the first state to legalize psilocybin for therapeutic use through the Oregon Psilocybin Services Act. From 2021 to 2022, the Oregon Health Authority and the Psilocybin Advisory Board created rules for the act and began taking applications on January 2, 2023.

Oregon also decriminalized personal possession of all drugs in 2020 through the Drug Addiction Treatment and Recovery Act, which went into effect in February 2021. Many of the provisions in that bill have since been reversed, with the possession of small amounts of hard drugs like fentanyl, methamphetamine and heroin being recriminalized as of September 1, 2024. However, psilocybin remains legal for therapeutic and facilitated use.

As of the end of March, Oregon Psilocybin Services counted 374 state-wide psilocybin facilitators, 29 service centers, 10 manufacturers and 808 worker permits. Satya Therapeutics, located in Ashland, is recognized as one of the state’s most experienced and successful service providers, with roughly 40 to 50 clients serviced monthly.

Publicly traded Florida-based cannabis company Kaya Holdings (OTCQB:KAYS) was awarded a license to operate a psilocybin service center in Oregon through its Fifth Dimension Therapeutics subsidiary in May 2024. Its treatment center, called the Sacred Mushroom, opened its doors in Portland on July 2, 2024.

In 2025, industry advocates are focused on analyzing outcomes from Oregon’s psychedelics program in order to fine tune areas requiring improvement. In February, state lawmakers sought to expand psychedelic therapy through the introduction of HB 3817, which establishes an access pathway for individuals with PTSD to access ibogaine. At the time of this writing, the bill had not yet been scheduled for a public hearing or committee vote.

Despite its growth, affordability has been a barrier to the development of Oregon’s psilocybin therapy program, with sessions typically costing over US$1,500. Some communities in the state also voted to ban psilocybin and psilocybin businesses in 2024, reflecting ongoing public concerns about drug liberalization.

In Colorado, a series of legislative actions regarding psychedelic substances led to state legalization in November 2022. Proposition 122 legalized the regulated access to psilocybin and psilocin in healing centers for adults over 21, decriminalized the personal use and cultivation of these substances and established a Natural Medicine Advisory Board.

SB 23-290, signed in May 2023, amended Proposition 122’s regulations and created a legal framework for healing centers. HB 22-1344, passed in June 2022, paved the way for MDMA-assisted therapy for PTSD if federally approved.

The final rules for licensed psilocybin therapy centers were filed with the secretary of state and became effective on December 15, 2024. Colorado then began accepting applications for licenses. In March, the Department of Revenue issued its first healing center license to the Center Origin in Denver. As of May 2 of this year, there were over 50 pending applications for healing centers, cultivation facilities and manufacturers.

As the psychedelics industry begins to take shape in Colorado, Tasia Poinsatte, the state’s director of the nonprofit Healing Advocacy Fund, told Stateline that centers plan to offer sliding-scale rates and discounts for veterans, Medicaid enrollees and low-income individuals to help address the affordability problem.

New psychedelics laws and research initiatives

Apart from Oregon and Colorado, a wave of legislative activity concerning psychedelics is evident across the US, with states like Illinois, Indiana, Missouri, Maine and New York pursuing various forms of legalization, including decriminalization, research funding and regulated therapeutic programs. Additionally, several cities in Washington and Michigan have decriminalized certain substances, with Washington also considering bills to create a regulated psilocybin services market and to provide funding to study ibogaine for opioid use disorder.

Utah passed legislation in March 2024 to create a program for psilocybin and MDMA as alternative treatments at the University of Utah Health and Intermountain Health. The program began in May 2024 and will run for three years.

Multiple institutions in Maryland, Texas and North Carolina are also conducting studies to assess the efficacy of psychedelics in treating various mental health conditions.

Senate Bill 242 established a working group tasked with studying the therapeutic use of entheogens in Nevada in 2023. A recommendations report was delivered in December 2024, and has garnered support from key legislative figures.

Several cities in California have deprioritized the enforcement of laws against the personal use and possession of certain psychedelics, and the state is considering a psilocybin pilot program for veterans and first responders.

Massachusetts has multiple bills focused on decriminalization and therapeutic pilot programs. In April of this year, New Mexico’s governor signed a bill for a therapeutic psilocybin program.

Meanwhile, Rhode Island has a bill that would legalize psilocybin possession if the federal government reschedules it, and Alaska established a task force in May 2024 to prepare for potential federal legalization of psychedelic therapies.

These actions reflect a shift in psychedelics sentiment and a growing trend of exploring their therapeutic potential.

Psychedelics investing options

To track the financial health of the psychedelic industry, investors can use the Psychedelic Invest Index, which monitors publicly traded companies in the space. Some of the top stocks in the index include Pasithea Therapeutics (NASDAQ:KTTA), MindMed (NASDAQ:MNMD), Compass Pathways (NASDAQ:CMPS) and Cybin (NYSEAMERICAN:CYBN), all of which are involved in developing psychedelic compounds for mental health treatments.

MindMed has developed a synthetic LSD analog, MM120, currently in Phase III trials for generalized anxiety disorder (GAD) and major depressive disorder (MDD). An oral tablet of MM120 was awarded a patent in July 2024.

Cybin has developed a proprietary deuterated psilocybin analog called CYB003, as well as CYB004, a proprietary deuterated DMT compound; both are protected by patents. The company also acquired SPL028, another deuterated DMT compound, through its merger with Small Pharma in 2023. Phase 2 CYB004 topline safety and efficacy data in GAD is expected in H1 2025. A pivotal study of CYB003 is scheduled for mid-2025.

Meanwhile, Compass Pathways’ Phase 2b randomized controlled study evaluating its synthetic psilocybin therapy, COMP360, was the most extensive psilocybin clinical trial to date. With data presented in 2022, the trial found that one 25 milligram dose of COMP360 resulted in a decline in depressive symptoms after three weeks when combined with psychological guidance, with positive effects reportedly lasting for as long as 12 weeks.

Other key players in the psychedelics market include atai Life Sciences (NASDAQ:ATAI), GH Research (NASDAQ:GHRS), Bright Minds Biosciences (NASDAQ:DRUG) and Silo Pharma (NASDAQ:SILO).

Canadian companies in this sector include Numinus Wellness (TSX:NUMI,OTCQB:MTPLF), Optimi Health (CSE:OPTI,OTCQX:OPTHF), BetterLife Pharma (CSE:BETR,OTCQB:BETRF), Pharmala Biotech (CSE:MDMA,OTCQB:MDXXF) and Restart Life Science (CSE:REST,OTC Pink:NMLSF).

Other avenues for investors include strategic investments in specialized real estate ventures.

Healing Realty Trust (HRT) specializes in acquiring healthcare infrastructure assets, focusing on developing mental and behavioral healthcare facilities. The company established preferred real estate partnership agreements with providers like NeuroSpa, Cambridge Biotherapies and Cathexis in 2024. It has also secured the first tranche of a US$25 million Series A funding round, with the funds earmarked to acquire healthcare facilities in Texas, Ohio and Connecticut.

HRT is reportedly preparing for an initial public offering, with a potential listing in late 2025 or early 2026.

Investor takeaway

Against this backdrop, the psychedelics market could see promising growth in 2025.

While challenges remain, the expansion of legalization and decriminalization, combined with ongoing research, positions the industry for growth and presents potential opportunities for investors.

Securities Disclosure: I, Meagen Seatter, hold direct investment interest in some of the companies mentioned in this article.

This post appeared first on investingnews.com

Edwards grabbed the ankle while on the court. The Timberwolves called timeout, and Edwards limped to the locker room with members of the team’s training staff.

Though the team listed Edwards as questionable to return to the game, he tested the ankle at halftime and was in the lineup to start the third quarter. Just before the third quarter began, the team had said he was available to return.

Edwards had seven points, four rebounds, three assists and three steals and the Timberwolves were ahead 37-19 when he left the game. Returning for the second half, he finished the game with 20 points, nine rebounds, five assists and three steals in 34 minutes as the Timberwolves cruised to a 117-93 win.

‘Feeling great, feeling great,” Edwards told TNT after the game when asked about his ankle.

Injuries continue to play a role in the playoffs. The Cleveland Cavaliers were without Darius Garland, Evan Mobley and De’Andre Hunter in their Game 2 loss to the Indiana Pacers, and Golden State Warriors star Steph Curry is out at least a week with a grade 1 left hamstring strain.

This story has been updated with new information.

The USA TODAY app gets you to the heart of the news — fastDownload for award-winning coverage, crosswords, audio storytelling, the eNewspaper and more.

This post appeared first on USA TODAY

The quest for the top prize in collegiate men’s lacrosse is underway. Over the weekend the remaining 16 teams will be in action, with the ultimate aim of lifting the national championship trophy on Memorial Day in Foxborough, Massachusetts.

Regular followers of the sport will notice a few name-brand programs missing from the NCAA tournament field. Long-time powers Virginia and Johns Hopkins as well as past champions Denver and Loyola (Md.) didn’t make the cut. But that doesn’t necessarily mean we’ll add a new member to the first-time champions club. Most of the seeded teams have won titles before, though it’s been a while for some.

Here’s the weekend schedule, with seeded teams playing on their home fields. The winners will advance to quarterfinal sites next weekend in Hempstead, New York, and Annapolis, Maryland.

NCAA lacrosse tournament title contenders

In a parallel with the recently concluded men’s basketball tournament, there is a team seeking a rare three-peat but facing a difficult path to achieving it. Two-time defending champion Notre Dame is seeking a third title in a row, a feat last accomplished by Princeton from 1996-98. As mentioned, however, it will be a tough path for the Fighting Irish, who did enough to make the field but not enough to earn a seed. They’ll start their title defense on the road at Big Ten tournament champ Ohio State, coincidentally the school that kept the Irish from claiming the crown in football. While it’s undoubtedly the most compelling matchup in the round of 16, the committee did neither team a favor with this pairing. The Buckeyes picked up a 10-9 win at Notre Dame back on March 8, but a season-opening loss to Utah damaged OSU’s overall seed. The game in Columbus isn’t the only rematch of the weekend. Harvard picked up a 15-14 win at Syracuse back on Feb. 22, a result that ultimately helped the Crimson edge out Army for the last at-large spot in the field.

NCAA lacrosse tournament top players

The undisputed star of the sport this year is Cornell’s CJ Kirst. The Tewaaraton Award favorite broke the Division I record for career goals earlier in the season. He enters the tournament with 98 points on 68 goals and 30 assists thus far in the campaign, averaging a lofty 6.53 points per contest. With the help of his friends on the Big Red attack unit, Ryan Goldstein and Michael Long, Cornell leads the nation in scoring at 16.47 goals a game. But one shouldn’t overlook reigning Championship Weekend most outstanding player Chris Kavanagh, back in the tournament for Notre Dame. Other names to know include Syracuse attackman Joey Spallina, Maryland goalkeeper Logan McNaney and Duke do-everything midfielder Andrew McAdorey.

Most likely first-time NCAA lacrosse tournament champion

Ohio State and Penn State have both been to Championship Weekend but have yet to bring home the trophy. Unfortunately, at least one of them won’t be in Foxborough, as they’d be slated to meet in the quarterfinal round should they survive this weekend. Like the Buckeyes, however, the Nittany Lions have a tough draw of their own against a high-scoring Colgate squad that got hot at the right time in the Patriot League tournament.

NCAA lacrosse tournament schedule

(All times Eastern)

First round

Saturday, May 10

Richmond (13-3) at North Carolina (10-4), noon

Towson (11-5) at Princeton (12-3), 2:30 p.m.

Colgate (10-7) at Penn State (10-4), 5 p.m.

Georgetown (11-4) at Duke (12-5), 7:30 p.m.

Sunday, May 11

Notre Dame (8-4) at Ohio State (14-2), noon

Air Force (9-7) at Maryland (11-3), 2:30 p.m.

Harvard (10-4) at Syracuse (11-5), 5 p.m.

Albany (10-8) at Cornell (14-1), 7:30 p.m.

This post appeared first on USA TODAY

With just a couple of weeks remaining in the college baseball regular season, fans are no doubt beginning to ponder how their favorite team’s path to Omaha might be shaping up. The easiest route, of course, involves being one of the top eight seeds that guarantees regional and super regional hosting rights. It is therefore advantageous if your team happens to be in the upper tier of the SEC standings or very high in the ACC hierarchy.

As of now, we project six of the top eight seeds to go to SEC members, with a couple more also slated to host regionals. Texas holds the top seed, but projected No. 2 Arkansas, seeking the program’s first national title, closed the gap with a sweep of the Longhorns last weekend.

The ACC should be well represented as well with three likely hosts among the top 16 teams. National contenders from the west coast are harder to find, but there should be at least three regionals in the Pacific time zone.

So who will occupy those spots and the rest of the field of 64 when it is revealed? Here’s our NCAA baseball tournament bracket projection with less than three weeks to go before Memorial Day:

(* denotes teams that are automatic qualifiers based on current conference standings.)

Austin region

  1. Texas* (1)
  2. Texas-San Antonio*
  3. Xavier
  4. SIU-Edwardsville*

Fayetteville region

  1. Arkansas (2)
  2. Duke
  3. Northeastern*
  4. Central Connecticut State*

Tallahassee region

  1. Florida State* (3)
  2. Florida
  3. Kansas
  4. Bethune-Cookman*

Athens region

  1. Georgia (4)
  2. Miami (Fla.)
  3. Troy
  4. Sacramento State*

Baton Rouge region

  1. LSU (5)
  2. Southern Mississippi
  3. Texas Rio Grande Valley
  4. Missouri State*

Clemson region

  1. Clemson (6)
  2. Dallas Baptist*
  3. Texas A&M
  4. Holy Cross*

Auburn region

  1. Auburn (7)
  2. Georgia Tech
  3. Connecticut
  4. Kent State*

Knoxville region

  1. Tennessee (8)
  2. Louisville
  3. Cal Poly
  4. Bryant*

Chapel Hill region

  1. North Carolina (9)
  2. Mississippi
  3. East Tennessee State*
  4. George Mason*

Nashville region

  1. Vanderbilt (10)
  2. Wake Forest
  3. Southeastern Louisiana*
  4. Oral Roberts*

Morgantown region

  1. West Virginia* (11)
  2. North Carolina State
  3. Mississippi State
  4. Austin Peay*

Corvallis region

  1. Oregon State (12)
  2. Southern California
  3. Arizona State
  4. San Diego*

Myrtle Beach region

  1. Coastal Carolina* (13)
  2. Alabama
  3. Kansas State
  4. High Point*

Los Angeles region

  1. UCLA (14)
  2. Arizona           
  3. Creighton*
  4. Wright State*

Fort Worth region

  1. TCU (15)
  2. Oklahoma
  3. Iowa*
  4. Columbia*

Irvine region

  1. UC Irvine* (16)
  2. Oregon
  3. Fairfield*
  4. Nevada*

Last four in: Troy, Kansas State, Xavier, Texas Rio Grand Valley.

Last four out: Kentucky, Western Kentucky, Michigan, Virginia.

Team breakdown by conference: SEC (13), ACC (9), Big 12 (6), Big Ten (4), Big East (3), Sun Belt (3), Big West (2), Southland (2).

This post appeared first on USA TODAY

It’s official! The opening and closing ceremonies for the 2028 Olympics and Paralympic Games will be hosted at the Los Angeles Memorial Coliseum and SoFi Stadium in Inglewood, California, LA28 announced on May 8.

The real catch is that for the first time in modern Olympics history, the opening ceremonies will be held at two venues at the same time.

While this is a historic occasion for the city of Los Angeles and the Olympics as a whole, the closing ceremonies will not be given the same luxury, though. Instead, the LA Coliseum will be the sole host for the finale.

This marks the third time that LA Coliseum has hosted the summer games (1932, 1984) and the first time for SoFi Stadium, which opened in 2020.

“For over a century, the Coliseum has been a landmark host to some of the most iconic moments in all of sports history,” said L.A. Mayor Karen Bass. “That story continues in 2028 as our City and our region welcomes the world for what will be the greatest Olympic and Paralympic Games.”

When are the 2028 Olympics?

Well, 2028 of course. The opening ceremony is set for July 14, 2028 with the closing ceremony happening two weeks later on July 30. The paralympics, meanwhile, will start on Aug. 15, 2028 and close August 27.

How has the United States done at Olympics hosted in LA?

The United States dominated the 1932 Olympics winning 110 medals in total, the most of the games. In fact, the United States had more gold medals (44) than any other country had total medals. Italy had the second-most medals with 36. They had exactly 12 gold, 12 silver, and 12 bronze.

At the 1984 Olympics, it was more of the same. The United States won 83 gold medals and 174 total medals. Romania finished second with just 20 gold medals, while West Germany tallied the second-most total medals with 59. The United States’ 83 gold medals in those games is an all-time record.

This post appeared first on USA TODAY